M Fjälling

1.4k total citations
37 papers, 1.1k citations indexed

About

M Fjälling is a scholar working on Epidemiology, Neurology and Oncology. According to data from OpenAlex, M Fjälling has authored 37 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Epidemiology, 11 papers in Neurology and 9 papers in Oncology. Recurrent topics in M Fjälling's work include Neuroendocrine Tumor Research Advances (17 papers), Neuroblastoma Research and Treatments (11 papers) and Lung Cancer Research Studies (7 papers). M Fjälling is often cited by papers focused on Neuroendocrine Tumor Research Advances (17 papers), Neuroblastoma Research and Treatments (11 papers) and Lung Cancer Research Studies (7 papers). M Fjälling collaborates with scholars based in Sweden and United Kingdom. M Fjälling's co-authors include Ola Nilsson, Eva Forssell‐Aronsson, Bo Wängberg, Lars‐Erik Tisell, H. Ahlman, Göran K. Hansson, Johan Mölne, L E Tisell, Svante Jansson and Bengt Nilsson and has published in prestigious journals such as Cancer, The Journal of Urology and British Journal of Cancer.

In The Last Decade

M Fjälling

37 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Fjälling Sweden 19 571 375 358 338 312 37 1.1k
Grant Cs United States 10 408 0.7× 479 1.3× 330 0.9× 307 0.9× 565 1.8× 13 1.0k
A. Berdelou France 19 337 0.6× 536 1.4× 367 1.0× 231 0.7× 350 1.1× 35 1.0k
Peter J. Mazzaglia United States 18 267 0.5× 374 1.0× 310 0.9× 153 0.5× 578 1.9× 28 1.1k
C. Ansquer France 19 176 0.3× 256 0.7× 229 0.6× 89 0.3× 360 1.2× 59 943
Shaunak Navalkissoor United Kingdom 17 596 1.0× 71 0.2× 582 1.6× 449 1.3× 172 0.6× 71 963
Agnese Barnabei Italy 18 321 0.6× 363 1.0× 706 2.0× 240 0.7× 137 0.4× 35 1.2k
Theo J. Klinkenberg Netherlands 12 136 0.2× 113 0.3× 142 0.4× 223 0.7× 215 0.7× 46 899
Klaus F. Gratz Germany 17 226 0.4× 41 0.1× 252 0.7× 92 0.3× 475 1.5× 44 909
J A Norton United States 13 486 0.9× 150 0.4× 483 1.3× 247 0.7× 351 1.1× 16 940
Antonio Castagnoli Italy 13 115 0.2× 549 1.5× 209 0.6× 200 0.6× 438 1.4× 40 1.3k

Countries citing papers authored by M Fjälling

Since Specialization
Citations

This map shows the geographic impact of M Fjälling's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Fjälling with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Fjälling more than expected).

Fields of papers citing papers by M Fjälling

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Fjälling. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Fjälling. The network helps show where M Fjälling may publish in the future.

Co-authorship network of co-authors of M Fjälling

This figure shows the co-authorship network connecting the top 25 collaborators of M Fjälling. A scholar is included among the top collaborators of M Fjälling based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Fjälling. M Fjälling is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Ahlman, Håkan, M Fjälling, Eva Forssell‐Aronsson, et al.. (2002). Indium-111-octreotide Scintigraphy, Intraoperative Gamma-detector Localisation and Somatostatin Receptor Expression in Primary Human Breast Cancer. Breast Cancer Research and Treatment. 74(2). 101–111. 12 indexed citations
2.
Stotzer, Per‐Ove, et al.. (1999). Assessment of Gastric Emptying (Comparison of Solid Scintigraphic Emptying and Emptying of Radiopaque Markers in Patients and Healthy Subjects). Digestive Diseases and Sciences. 44(4). 729–734. 41 indexed citations
3.
Lindnér, Per, M Fjälling, L Hafström, et al.. (1999). Isolated hepatic perfusion with extracorporeal oxygenation using hyperthermia, tumour necrosis factor alpha and melphalan. European Journal of Surgical Oncology. 25(2). 179–185. 36 indexed citations
4.
Tisell, L E, H. Ahlman, Bo Wängberg, et al.. (1999). Expression of somatostatin receptors in oncocytic (Hürthle cell) neoplasia of the thyroid. British Journal of Cancer. 79(9-10). 1579–1582. 16 indexed citations
5.
Ahlman, H., L E Tisell, Bo Wängberg, et al.. (1999). The relevance of somatostatin receptors in thyroid neoplasia.. PubMed. 70(5-6). 523–33. 8 indexed citations
6.
Nilsson, Ola, Lars Kölby, Bo Wängberg, et al.. (1998). Comparative studies on the expression of somatostatin receptor subtypes, outcome of octreotide scintigraphy and response to octreotide treatment in patients with carcinoid tumours. British Journal of Cancer. 77(4). 632–637. 88 indexed citations
7.
Tisell, L E, H. Ahlman, Bo Wängberg, et al.. (1997). Somatostatin receptor scintigraphy in medullary thyroid carcinoma. British journal of surgery. 84(4). 543–547. 36 indexed citations
8.
Wängberg, Bo, Ola Nilsson, Viktor Johanson, et al.. (1997). Somatostatin Receptors in the Diagnosis and Therapy of Neuroendocrine Tumors. The Oncologist. 2(1). 50–58. 38 indexed citations
9.
Carneskog, Jan, Hans Wadenvik, M Fjälling, & Jack Kutti. (1996). Assessment of spleen size using gamma camera scintigraphy in newly diagnosed patients with essential thrombocythaemia and polycythaemia vera. European Journal Of Haematology. 56(3). 158–162. 15 indexed citations
10.
Wängberg, Bo, et al.. (1996). Intraoperative detection of somatostatin-receptor-positive neuroendocrine tumours using indium-111-labelled DTPA-D-Phe1-octreotide. British Journal of Cancer. 73(6). 770–775. 29 indexed citations
11.
Fjälling, M, Peder Andersson, Eva Forssell‐Aronsson, et al.. (1996). Systemic radionuclide therapy using indium-111-DTPA-D-Phe1-octreotide in midgut carcinoid syndrome.. PubMed. 37(9). 1519–21. 71 indexed citations
12.
Fjälling, M, et al.. (1996). Liver uptake function measured by IODIDA clearance rate in liver transplant patients and healthy volunteers. Nuclear Medicine Communications. 17(3). 235–242. 60 indexed citations
13.
Jacobsson, Lars, et al.. (1995). The chemical nature, purity and stability of 99mTc-N-(2,6-diethyl-3-iodo-phenylcarbamoylmethyl)-iminodiacetic acid. Nuclear Medicine and Biology. 22(4). 521–525. 2 indexed citations
14.
Forssell‐Aronsson, Eva, M Fjälling, Ola Nilsson, et al.. (1995). Indium-111 activity concentration in tissue samples after intravenous injection of indium-111-DTPA-D-Phe-1-octreotide.. PubMed. 36(1). 7–12. 38 indexed citations
15.
Ahlman, H., Tisell Le, Bo Wängberg, et al.. (1994). Somatostatin receptors on neuroendocrine tumors--a way to intraoperative diagnosis and localization.. PubMed Central. 67(3-4). 215–21. 9 indexed citations
16.
Ahlman, H., Bo Wängberg, L E Tisell, et al.. (1994). Clinical efficacy of octreotide scintigraphy in patients with midgut carcinoid tumours and evaluation of intraoperative scintillation detection. British journal of surgery. 81(8). 1144–1149. 44 indexed citations
17.
Fjälling, M, et al.. (1992). IODIDA clearance rate: a method for measuring hepatocyte uptake function.. PubMed. 24(1). 387–8. 38 indexed citations
18.
Fjälling, M, et al.. (1992). Kupffer cell and hepatocyte function in rat transplanted liver. PubMed. 5 Suppl 1. 417–419. 4 indexed citations
19.
Lindberg, S., et al.. (1988). Methodology and dosimetry in adrenal medullary imaging with iodine-131 MIBG.. PubMed. 29(10). 1638–43. 13 indexed citations
20.
Fjälling, M, et al.. (1986). Benign and malignant thyroid nodules after neck irradiation. Cancer. 58(6). 1219–1224. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026